Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AATICC Pilot: Empiric Antibiotics in Critical Care
NCT00438269Phase 2Completed
- Sponsor
- Canadian Critical Care Trials Group
- Start
- Feb 2003
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of meropenem, piperacillin, tazobactam, ciprofloxacin, cefazolin in nosocomial infection, pneumonia, sponsored by Canadian Critical Care Trials Group. Started Feb 2003; status: completed.
02
Drugs
03
Conditions
nosocomial infectionpneumonia
Beyond the preview
Go deeper on NCT00438269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00438269.